ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
ACCENDRA HEALTH INC/VA/
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.22−0.01 (-6.30%)
Close on Oct 19, 2026
- Market cap
- $16.89M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
81.1%
62M of 77M shares
Institutional holders
140
21 new, 21 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Bank Of America Corp /De/ | 8,270,614 | 10.80% | 13G (passive) | Sep 30, 2026 |
| BlackRock, Inc. | 5,454,051 | 7.10% | 13G (passive) amendment | Sep 30, 2025 |
| Kevin M. Webb | 4,287,431 | 5.61% | 13G (passive) | Mar 12, 2026 |
| Adam Gray | 13,100,807 | 16.90% | 13D (active) | Nov 12, 2025 |
| Christopher Shackelton | 11,562,955 | 15.10% | 13G (passive) amendment | Mar 31, 2025 |
| Coliseum Capital Management, LLC | 10,624,599 | 13.80% | 13G (passive) amendment | Feb 28, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ACH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Coliseum Capital Management, LLC | 13,100,807 | 17.04% | $44.80M | – | 3.85% |
| BlackRock, Inc. | 5,504,102 | 7.16% | $18.82M | +268,802 | 0.00% |
| Bank Of America Corp /De/ | 3,775,525 | 4.91% | $12.91M | +368,450 | 0.00% |
| Vanguard Capital Management LLC | 3,087,931 | 4.02% | $10.56M | −194,243 | 0.00% |
| D. E. Shaw & Co., Inc. | 3,081,407 | 4.01% | $10.54M | −230,194 | 0.01% |
| Charles Schwab Investment Management Inc | 2,888,058 | 3.76% | $9.88M | −747,468 | 0.00% |
| Invenomic Capital Management LP | 2,812,474 | 3.66% | $9.62M | −556,501 | 0.57% |
| Marshall Wace, Llp | 2,582,579 | 3.36% | $8.83M | +821,575 | 0.01% |
| Paradigm Capital Management Inc/Ny | 2,536,699 | 3.30% | $8.68M | +750,299 | 0.24% |
| Vanguard Portfolio Management LLC | 2,030,956 | 2.64% | $6.95M | −620,196 | 0.00% |
| Dana Investment Advisors, Inc. | 1,944,607 | 2.53% | $6.65M | +459,510 | 0.17% |
| Geode Capital Management, LLC | 1,873,127 | 2.44% | $6.41M | +37,217 | 0.00% |
| Dimensional Fund Advisors LP | 1,640,163 | 2.13% | $5.61M | −966,457 | 0.00% |
| State Street Corp | 1,601,162 | 2.08% | $5.48M | −28,794 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 1,288,787 | 1.68% | $4.41M | −91,941 | 0.01% |
| Aqr Capital Management LLC | 1,067,324 | 1.39% | $3.65M | +335,103 | 0.00% |
| Goldman Sachs Group Inc | 854,730 | 1.11% | $2.92M | −86,443 | 0.00% |
| Acadian Asset Management LLC | 820,070 | 1.07% | $2.80K | −87,026 | 0.00% |
| Two Sigma Investments, LP | 718,550 | 0.93% | $2.46M | −482,719 | 0.00% |
| Northern Trust Corp | 581,804 | 0.76% | $1.99M | −19,157 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 140 | 62M | 81.1% | 21 / 44 | 46 / 21 | 5M | 6M |
| Q1 2026 | 142 | 63M | 82.0% | 28 / 37 | 51 / 50 | 13M | 13M |
| Q4 2025 | 168 | 69M | 89.7% | 25 / 54 | 67 / 54 | 10M | 13M |
| Q3 2025 | 202 | 73M | 94.5% | 34 / 70 | 71 / 66 | 19M | 21M |
| Q2 2025 | 234 | 75M | 97.4% | 35 / 89 | 81 / 42 | 12M | 11M |
| Q1 2025 | 242 | 74M | 96.7% | 64 / 86 | 63 / 18 | 17M | 18M |
| Q4 2024 | 198 | 76M | 98.8% | 26 / 65 | 73 / 41 | 4M | 5M |
| Q3 2024 | 214 | 77M | 100.0% | 32 / 76 | 74 / 37 | 22M | 11M |
| Q2 2024 | 221 | 78M | 100.0% | 37 / 71 | 76 / 44 | 5M | 8M |
| Q1 2024 | 231 | 80M | 100.0% | 40 / 62 | 94 / 35 | 8M | 7M |
| Q4 2023 | 227 | 79M | 100.0% | 39 / 69 | 90 / 21 | 8M | 9M |
| Q3 2023 | 211 | 81M | 100.0% | 21 / 72 | 84 / 39 | 10M | 4M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ACH | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2,185,973 | 2.84% | $7.48M | 0.00% | Jun 30, 2026 |
| Schwab Fundamental U.S. Small Company ETF | 2,129,351 | 2.77% | $6.05M | 0.07% | May 31, 2026 |
| iShares Russell 2000 ETF | 1,923,816 | 2.50% | $6.58M | 0.01% | Jun 30, 2026 |
| PIMCO RAE US Small Fund | 1,782,049 | 2.32% | $6.09M | 0.16% | Jun 30, 2026 |
| Invenomic Fund | 913,665 | 1.19% | $2.82M | 0.33% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 833,270 | 1.08% | $2.85M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 784,933 | 1.02% | $2.43M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 670,993 | 0.87% | $2.29M | 0.02% | Jun 30, 2026 |
| Vanguard U.S. Value Factor ETF | 519,411 | 0.68% | $1.48M | 0.18% | May 31, 2026 |
| Vanguard Strategic Small-Cap Equity Fund | 507,198 | 0.66% | $1.73M | 0.06% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 482,864 | 0.63% | $1.49M | 0.01% | Jul 31, 2026 |
| U.S. Targeted Value Portfolio | 470,339 | 0.61% | $1.45M | 0.01% | Jul 31, 2026 |
| Schwab Fundamental U.S. Small Company Index Fund | 450,715 | 0.59% | $1.39M | 0.06% | Jul 31, 2026 |
| Vanguard Strategic Equity Fund | 427,891 | 0.56% | $1.46M | 0.01% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 387,415 | 0.50% | $1.10M | 0.01% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Edward A. Pesicka | President & CEO, Director | 1,072,785 | 1.39% | May 19, 2026 |
| Jonathan A. Leon | EVP & CFO | 286,268 | 0.37% | Sep 24, 2026 |
| Heath H. Galloway | EVP,General Counsel & CorpSecy | 166,306 | 0.22% | May 20, 2026 |
| Perry A. Bernocchi | EVP, Chief Operating Officer | 313,913 | 0.41% | May 19, 2026 |
| Andrew G. Long | EVP, CEO P&HS | 448,425 | 0.58% | Nov 20, 2025 |
| Jennifer A. Stone | EVP, CHRO | 110,327 | 0.14% | Jun 4, 2025 |
| Michael Wayne Lowry | SVP, Corporate Controller | 121,921 | 0.16% | May 16, 2025 |
| Stephen W. Klemash | Director | 90,242 | 0.12% | May 18, 2026 |
| Gwendolyn M. Bingham | Director | 22,184 | 0.03% | May 18, 2026 |
| Kenneth Gardner-Smith | Director | 86,113 | 0.11% | May 18, 2026 |
| Teresa L. Kline | Director | 85,316 | 0.11% | May 18, 2026 |
| Mark A. Beck | Director | 71,259 | 0.09% | May 18, 2026 |
| Carissa Rollins | Director | 53,902 | 0.07% | May 16, 2025 |
| Rita Johnson-Mills | Director | 54,125 | 0.07% | May 16, 2025 |
| Robert J. Henkel | Director | 77,412 | 0.10% | May 16, 2025 |
| Christopher S. Shackelton | 10% owner | 10,624,599 | 13.82% | Aug 14, 2025 |
| Coliseum Capital, LLC | 10% owner | 11,562,955 | 15.04% | Aug 14, 2025 |
| Coliseum Capital Management, LLC | 10% owner | 11,152,955 | 14.50% | Aug 14, 2025 |
| Adam Gray | 10% owner | 7,731,187 | 10.05% | Aug 14, 2025 |
| Coliseum Capital Partners, L.P. | 10% owner | 13,100,807 | 17.04% | Aug 14, 2025 |
| Snehashish Sarkar | – | 108,586 | 0.14% | May 16, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jonathan A. Leon EVP & CFO | Sep 23, 2026 | Tax withholding | −4,265 | $0.85 | $3.63K | 286,268 |
| Heath H. Galloway EVP,General Counsel & CorpSecy | May 18, 2026 | Tax withholding | −1,822 | $2.91 | $5.30K | 166,306 |
| Edward A. Pesicka President & CEO, Director | May 15, 2026 | Tax withholding | −17,692 | $3.04 | $53.78K | 1,072,785 |
| Heath H. Galloway EVP,General Counsel & CorpSecy | May 15, 2026 | Tax withholding | −966 | $3.04 | $2.94K | 168,128 |
| Jonathan A. Leon EVP & CFO | May 15, 2026 | Tax withholding | −1,770 | $3.04 | $5.38K | 290,533 |
| Perry A. Bernocchi EVP, Chief Operating Officer | May 15, 2026 | Tax withholding | −7,908 | $3.04 | $24.04K | 313,913 |
| Stephen W. Klemash Director | May 14, 2026 | Award | +31,191 | – | – | 90,242 |
| Kenneth Gardner-Smith Director | May 14, 2026 | Award | +31,191 | – | – | 86,113 |
| Mark A. Beck Director | May 14, 2026 | Award | +31,191 | – | – | 71,259 |
| Teresa L. Kline Director | May 14, 2026 | Award | +31,191 | – | – | 85,316 |
| Heath H. Galloway EVP,General Counsel & CorpSecy | Mar 20, 2026 | Tax withholding | −9,347 | $2.03 | $18.97K | 169,094 |
| Perry A. Bernocchi EVP, Chief Operating Officer | Mar 20, 2026 | Tax withholding | −20,841 | $2.03 | $42.31K | 321,821 |
| Jonathan A. Leon EVP & CFO | Mar 20, 2026 | Tax withholding | −11,286 | $2.03 | $22.91K | 292,303 |
| Edward A. Pesicka President & CEO, Director | Mar 20, 2026 | Tax withholding | −58,945 | $2.03 | $119.66K | 1,090,477 |
| Perry A. Bernocchi EVP, Chief Operating Officer | Mar 9, 2026 | Award | +108,696 | – | – | 342,662 |
| Jonathan A. Leon EVP & CFO | Mar 9, 2026 | Award | +85,067 | – | – | 303,589 |
| Heath H. Galloway EVP,General Counsel & CorpSecy | Mar 9, 2026 | Award | +61,437 | – | – | 178,441 |
| Andrew G. Long EVP, CEO P&HS | Nov 19, 2025 | Gift | −47,908 | – | – | 214,064 |
| Jonathan A. Leon EVP & CFO | Sep 23, 2025 | Tax withholding | −4,265 | $5.40 | $23.03K | 218,522 |
| Coliseum Capital Partners, L.P. 10% owner | Aug 14, 2025 | Buy | +492,852 | $5.31 | $2.62M | 13,100,807 |
| Coliseum Capital Partners, L.P. 10% owner | Aug 13, 2025 | Buy | +325,000 | $5.46 | $1.77M | 12,607,955 |
| Coliseum Capital Partners, L.P. 10% owner | Aug 12, 2025 | Buy | +720,000 | $5.15 | $3.71M | 12,282,955 |
| Jennifer A. Stone EVP, CHRO | Jun 3, 2025 | Tax withholding | −5,764 | $6.35 | $36.60K | 110,327 |
| Heath H. Galloway EVP,General Counsel & CorpSecy | May 19, 2025 | Tax withholding | −1,768 | $7.38 | $13.05K | 117,044 |
| Jonathan A. Leon EVP & CFO | May 15, 2025 | Tax withholding | −2,641 | $7.00 | $18.49K | 222,787 |
| Edward A. Pesicka President & CEO, Director | May 15, 2025 | Tax withholding | −35,208 | $7.00 | $246.46K | 1,149,422 |
| Carissa Rollins Director | May 15, 2025 | Award | +28,914 | – | – | 53,902 |
| Snehashish Sarkar – | May 15, 2025 | Tax withholding | −4,336 | $7.00 | $30.35K | 108,586 |
| Teresa L. Kline Director | May 15, 2025 | Award | +28,914 | – | – | 54,125 |
| Kenneth Gardner-Smith Director | May 15, 2025 | Award | +28,914 | – | – | 54,922 |
| Andrew G. Long EVP, CEO P&HS | May 15, 2025 | Tax withholding | −19,081 | $7.00 | $133.57K | 261,972 |
| Rita Johnson-Mills Director | May 15, 2025 | Award | +28,914 | – | – | 54,125 |
| Heath H. Galloway EVP,General Counsel & CorpSecy | May 15, 2025 | Tax withholding | −1,315 | $7.00 | $9.21K | 118,772 |
| Michael Wayne Lowry SVP, Corporate Controller | May 15, 2025 | Tax withholding | −1,533 | $7.00 | $10.73K | 121,921 |
| Stephen W. Klemash Director | May 15, 2025 | Award | +28,914 | – | – | 59,051 |
| Mark A. Beck Director | May 15, 2025 | Award | +28,914 | – | – | 40,068 |
| Robert J. Henkel Director | May 15, 2025 | Award | +28,914 | – | – | 77,412 |
| Perry A. Bernocchi EVP, CEO,. Patient Direct | May 15, 2025 | Tax withholding | −13,394 | $7.00 | $93.76K | 233,966 |
| Coliseum Capital, LLC 10% owner | Apr 10, 2025 | Buy | +80,000 | $7.19 | $575.20K | 11,562,955 |
| Coliseum Capital, LLC 10% owner | Apr 9, 2025 | Buy | +225,000 | $7.39 | $1.66M | 11,482,955 |
| Coliseum Capital, LLC 10% owner | Apr 8, 2025 | Buy | +105,000 | $7.96 | $835.80K | 11,257,955 |
| Coliseum Capital Management, LLC 10% owner | Apr 7, 2025 | Buy | +240,000 | $7.84 | $1.88M | 11,152,955 |
| Coliseum Capital Management, LLC 10% owner | Apr 4, 2025 | Buy | +128,356 | $8.14 | $1.04M | 10,912,955 |
| Coliseum Capital Management, LLC 10% owner | Apr 3, 2025 | Buy | +160,000 | $8.53 | $1.36M | 10,784,599 |
| Andrew G. Long EVP, CEO P&HS | Mar 20, 2025 | Tax withholding | −4,578 | $10.09 | $46.19K | 281,053 |
| Heath H. Galloway EVP,General Counsel & CorpSecy | Mar 20, 2025 | Tax withholding | −2,734 | $10.09 | $27.59K | 120,087 |
| Jonathan A. Leon EVP & CFO | Mar 20, 2025 | Tax withholding | −1,961 | $10.09 | $19.79K | 225,428 |
| Snehashish Sarkar – | Mar 20, 2025 | Tax withholding | −1,977 | $10.09 | $19.95K | 112,922 |
| Edward A. Pesicka President & CEO, Director | Mar 20, 2025 | Tax withholding | −14,715 | $10.09 | $148.47K | 1,184,630 |
| Perry A. Bernocchi EVP, CEO,. Patient Direct | Mar 20, 2025 | Tax withholding | −5,551 | $10.09 | $56.01K | 247,360 |
| Michael Wayne Lowry SVP, Corporate Controller | Mar 20, 2025 | Tax withholding | −1,059 | $10.09 | $10.69K | 123,454 |
| Christopher S. Shackelton 10% owner | Mar 4, 2025 | Buy | +800,000 | $9.75 | $7.80M | 10,624,599 |
| Edward A. Pesicka President & CEO, Director | Mar 3, 2025 | Award | +445,279 | – | – | 1,199,345 |
| Michael Wayne Lowry SVP, Corporate Controller | Mar 3, 2025 | Award | +28,166 | – | – | 124,513 |
| Heath H. Galloway EVP,General Counsel & CorpSecy | Mar 3, 2025 | Award | +69,743 | – | – | 122,821 |
| Snehashish Sarkar – | Mar 3, 2025 | Award | +59,013 | – | – | 114,899 |
| Perry A. Bernocchi EVP, CEO,. Patient Direct | Mar 3, 2025 | Award | +123,391 | – | – | 252,911 |
| Jonathan A. Leon EVP, Chief Financial Officer | Mar 3, 2025 | Award | +134,121 | – | – | 285,631 |
| Andrew G. Long EVP, CEO P&HS | Mar 3, 2025 | Award | +134,121 | – | – | 285,631 |
| Jennifer A. Stone EVP, CHRO | Mar 3, 2025 | Award | +59,013 | – | – | 116,091 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Coliseum Capital Management, LLC 10% Stockholder | Sep 11, 2026 | 21,453,518 | $23.17M | Sep 11, 2026 | Open Market Purchases. Please refer to explanatory notes under "Remarks" below. |
| Jonathan A. Leon Officer | Nov 21, 2024 | 5,282 | $62.43K | Nov 21, 2024 | Restricted Stock Vesting |
| Snehashish Sarkar Officer | Nov 18, 2024 | 2,055 | $25.19K | Nov 18, 2024 | Restricted Stock Vesting |
| Alexander J. Bruni Former Officer | Sep 20, 2024 | 3,384 | $53.92K | Sep 20, 2024 | Restricted Stock Vesting |
| Jonathan A. Leon Officer | Aug 22, 2024 | 7,500 | $118.73K | Aug 22, 2024 | Restricted Stock Vesting |
| Alexander J. Bruni Former Officer | Aug 16, 2024 | 635 | $10.16K | Aug 16, 2024 | Restricted Stock Vesting |
| Daniel J. Starck Former Officer | Jul 23, 2024 | 23,183 | $389.26K | Jul 23, 2024 | Restricted Stock Vesting |
| Perry A. Bernocchi Officer | Jun 6, 2024 | 20,015 | $350.00K | Jun 6, 2024 | Restricted Stock Vesting |
| Mark A. Beck Director | Jun 5, 2024 | 9,344 | $161.18K | Jun 5, 2024 | Restricted Stock Vesting |
| Snehashish Sarkar Officer | Jun 4, 2024 | 9,980 | $172.85K | Jun 4, 2024 | Restricted Stock Vesting |
| Alexander J. Bruni Officer | Jun 3, 2024 | 10,568 | $187.69K | Jun 3, 2024 | Restricted Stock Vesting |
| Heath H. Galloway Officer | May 17, 2024 | 2,052 | $39.11K | May 17, 2024 | Restricted Stock Vesting |
| Heath H. Galloway Officer | May 16, 2024 | 2,031 | $40.99K | May 16, 2024 | Restricted Stock Vesting |
| Perry A. Bernocchi Officer | May 1, 2024 | 24,094 | $585.68K | May 1, 2024 | ESPP Purchase |
| Jonathan A. Leon Officer | Apr 22, 2024 | 5,000 | $124.20K | Apr 22, 2024 | Restricted Stock Vesting |